Oramed Pharm's total assets for Q3 2025 were $220.49M, an increase of 36.37% from the previous quarter. ORMP total liabilities were $18.16M for the fiscal quarter, a 124.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.